# Safety of Inhaled Insulin With Type 1 and Type 2 Diabetes

> **NCT00308737** · PHASE3 · COMPLETED · sponsor: **Mannkind Corporation** · enrollment: 2053 (actual)

## Conditions studied

- Diabetes, Type 1
- Diabetes, Type 2

## Interventions

- **DRUG:** Technosphere® Insulin Inhalation Powder
- **DRUG:** Usual Care

## Key facts

- **NCT ID:** NCT00308737
- **Lead sponsor:** Mannkind Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-06
- **Primary completion:** 2008-09
- **Final completion:** 2008-10
- **Target enrollment:** 2053 (ACTUAL)
- **Last updated:** 2014-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00308737

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00308737, "Safety of Inhaled Insulin With Type 1 and Type 2 Diabetes". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT00308737. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*